Counterclaims Dropped In Merck-Sandoz Patent Suit

Law360, New York (May 24, 2010, 4:12 PM EDT) -- A judge has dismissed some of Sandoz Inc.'s counterclaims against Merck & Co. Inc. in a patent dispute over Sandoz's plans for a generic version of Merck's anti-nausea drug Emend.

Judge Mary Cooper of the U.S. District Court for the District of New Jersey on Friday dismissed Sandoz's claims against Merck and GlaxoSmithKline PLC related to two patents. Counsel for Sandoz sent a letter to Judge Cooper on Wednesday enclosing a proposed order of dismissal but included no further details.

Paul da Costa, an attorney for...
To view the full article, register now.